文献速递内脏/肾动脉与血管畸形

逆行开放肠系膜支架置入术治疗急性肠系膜缺血的十年经验

A decade's experience with retrograde open mesenteric stenting for acute mesenteric ischemia.
PubMed 文献 · J Vasc Surg · 2024-05-14

回顾2011至2022年42例急性肠系膜缺血患者接受逆行开放肠系膜支架置入术(ROMS),技术成功40例(95.2%),院内死亡13例(32.5%),30天死亡9例(22.5%),Kaplan-Meier分析1年总生存率58.6%、支架一期通畅率51.4%。作者认为ROMS技术成功率高、死亡率低于传统报告,可作为急性肠系膜缺血的治疗选择。

要点

  • 42例急性肠系膜缺血患者尝试ROMS,技术成功40例(95.2%)。
  • 院内死亡13例(32.5%),30天死亡9例(22.5%),1年总生存率58.6%。
  • 支架1年一期通畅率51.4%,30天脓毒症8例(20.0%)。

核心结论

  • ROMS治疗急性肠系膜缺血的技术成功率高,死亡率低于传统报告的急性肠系膜缺血死亡率。
  • 作者认为快速血运重建与肠道评估的双重优势使该手术方式成为急性肠系膜缺血的治疗选择。

研究设计与样本

  • 回顾性分析2011年至2022年所有接受ROMS治疗的急性肠系膜缺血患者,共42例。
  • 分析患者人口学特征、临床表现、手术细节和结局,主要终点为院内、30天和1年死亡率,并生成1年死亡率和一期通畅丢失的Kaplan-Meier估计。

主要发现

  • 中位年龄70±15岁,多数为女性;与体格检查不成比例的疼痛为最常见表现(n=18,42.9%),其次为腹膜炎(n=14,33.4%)。
  • 36例(85.7%)的原因为原位血栓形成;40例(95.2%)技术成功,均行肠系膜上动脉血管成形和支架置入,35例(87.5%)置入单个支架,其余置入一个以上支架。
  • 80%的患者需要肠切除,34例(85.0%)需要二次剖腹探查;平均手术时间192±57分钟。
  • 30天内最常见并发症为脓毒症,8例(20.0%);院内死亡13例(32.5%),30天内死亡9例(22.5%)。
  • Kaplan-Meier分析1年总生存率为58.6%,支架一期通畅率为51.4%。

临床怎么用

  • 作者认为ROMS治疗急性肠系膜缺血的技术成功率高、死亡率低于传统报告,快速血运重建与肠道评估的双重优势使其成为急性肠系膜缺血的治疗选择。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Retrograde open mesenteric stenting (ROMS) is an alternative to mesenteric bypass in patients with acute mesenteric ischemia (AMI) with variable reported 30-day mortality rates. Large studies evaluating patient outcomes following ROMS are scarce. Our study aims to assess the results of this approach among patients presenting with AMI. METHODS: We reviewed all the patients with AMI who were treated with ROMS (2011-2022). Patient demographics, presentation, operative details, and outcomes were analyzed. Primary end points were in-hospital, 30-day, and 1-year mortality. Kaplan-Meier estimate for 1-year mortality and primary patency loss were generated. Secondary end points included postoperative 30-day complications. RESULTS: Between 2011 and 2022, ROMS was attempted on a total of 42 patients. The median age was 70 ± 15 years and the majority of patients were female. Pain out of proportion to the physical examination was the most common presenting symptom (n = 18, 42.9%) followed by peritonitis (n = 14, 33.4%). All patients underwent preoperative intravenous contrast computed tomography imaging. In situ thrombosis was identified as the etiology of AMI in 36 patients (85.7%). Technical success was achieved in 40 patients (95.2%). Conventional, non-hybrid operating rooms were used for the majority of cases. Revascularization of all 40 patients involved angioplasty and stenting of superior mesenteric artery. A single stent was placed in 35 patients (87.5%) and the reminder had more than one stent. Eighty percent of patients required bowel resection. A second-look laparotomy was required in 34 patients (85.0%). The mean operative time, including both the general surgery and vascular surgery portions of the index procedure, was 192 ± 57 minutes. Sepsis was the most common complication observed within 30 days, occurring in 8 patients (20.0%). In terms of mortality, 13 patients (32.5%) died during their index hospitalization, and 9 died (22.5%) within 30 days. On Kaplan-Meier analysis, the 1-year overall patient survival rate was 58.6%, and the primary patency rate for stents was 51.4%. CONCLUSIONS: ROMS has an excellent technical success rate in management of AMI with lower than traditionally reported mortality rates for AMI. The dual benefits of rapid revascularization and bowel evaluation should make this surgical modality an alternative approach for treatment of AMI.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Habib SG, Semaan DB, Andraska EA, et al. A decade's experience with retrograde open mesenteric stenting for acute mesenteric ischemia. J Vasc Surg. 2024. PMID: 38750941. doi:10.1016/j.jvs.2024.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。